Recent conventional clinical trials have not convincingly shown the superiority of V-A ECMO in acute myocardial infarction complicated by cardiogenic shock as compared with medical therapy alone. Though, it has repeatedly been reported that the addition of interventional left ventricular unloading to V-A ECMO may improve clinical outcome. Novel approaches such as registry-based adaptive platform trials and computational physiological modeling are now introduced to inform clinicians by aiming to better account for patient-specific variation and complexity inherent to V-A ECMO and have raised a widespread interest. To provide modern high-quality V-A ECMO care, it remains essential to understand the patient's pathophysiology and the intricate interaction of an individual patient with extracorporeal circulatory support devices. Innovative clinical trial design and computational modeling approaches carry great potential towards advanced clinical decision support in ECMO and related critical care.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- left ventricular
- clinical trial
- acute myocardial infarction
- clinical decision support
- respiratory failure
- healthcare
- heart failure
- palliative care
- case report
- mitral valve
- cardiac resynchronization therapy
- percutaneous coronary intervention
- mechanical ventilation
- aortic stenosis
- electronic health record
- phase ii
- study protocol
- open label
- bone marrow
- left atrial
- stem cells
- high throughput
- coronary artery disease
- acute coronary syndrome
- health insurance